Breaking News Instant updates and real-time market news.

SAGE

Sage Therapeutics

$45.64

-0.41 (-0.89%)

07:26
10/04/16
10/04
07:26
10/04/16
07:26

SAGE Therapeutics reinstated with an Outperform at Leerink

Leerink analyst Paul Matteis resumed coverage of SAGE Therapeutics with an Outperform rating and $68 price target.

  • 07

    Oct

  • 06

    Nov

SAGE Sage Therapeutics
$45.64

-0.41 (-0.89%)

08/10/16
RHCO
08/10/16
NO CHANGE
RHCO
SAGE Therapeutics shares should be bought following decline, says SunTrust
After SAGE announced that the results of a Phase III trial of its SRSE drug would be delayed until 1H17 from 2H16 due to slower than expected enrollment, SunTrust analyst Edward Nash says the delay does not affect his timetable for the drug's commercial launch. The analyst does not expect changes to the protocol amendment to meaningfully affect patient characteristics or the results. He reiterates a $95 price target and Buy rating on the shares.
09/06/16
ADAM
09/06/16
NO CHANGE
Target $110
ADAM
Buy
SAGE Therapeutics breakthrough designation rare for FDA, says Canaccord
Canaccord analyst John Newman said SAGE Therapeutics' breakthrough designation for SAGE-547 is rare for the FDA to give in central nervous system disorders, suggesting the agency was impressed with the clinical data. Newman expects the breakthrough status to shorten the regulatory timing and allow for more flexibility in study design. The analyst rates SAGE a Buy with a $110 price target.
09/07/16
ROTH
09/07/16
NO CHANGE
Target $149
ROTH
Buy
Ligand has 'major catalyst' ahead, says Roth Capital
Roth Capital analyst Joseph Pantginis says Ligand (LGND) is expecting a "major catalyst" this month namely the Phase IIb sparsentan data in focal segmental glomerulosclerosis patients being developed by partner Retrophin (RTRX). In a separate note to investors, Pantginis also said that the Breakthrough Therapy Designation of SAGE Therapeutics' (SAGE) '547 for postpartum depression may expedite its development and approval for use in the clinic, noting that the company has an agreement of 3% royalty payment to Ligand for potential sales of the drug. The analyst recommends steady accumulation of Ligand's stock as he anticipates that current revenue streams from partnered products and the broad "in development" portfolio are poised to drive significant growth in the near and longer term. He reiterates a Buy rating and $149 price target on Ligand's shares.
09/13/16
RAJA
09/13/16
INITIATION
Target $75
RAJA
Outperform
SAGE Therapeutics initiated with an Outperform at Raymond James
Raymond James analyst Christopher Raymond initiated SAGE Therapeutics with an Outperform and a $75 price target. Raymond likes the setup on SAGE shares as key validation of its unique central nervous system drug development approach nears through pivotal SAGE-547 data, expected 1H 2017. Combining this with a pipeline holding numerous unmodeled call options and a platform capable of generating novel agents in a space lacking innovation, he believes shares will move higher.

TODAY'S FREE FLY STORIES

XLF

Financial Select Sector

$23.89

-0.09 (-0.38%)

, XLV

Health Care Select Sector SPDR

$80.47

-0.12 (-0.15%)

08:11
06/26/17
06/26
08:11
06/26/17
08:11
Technical Analysis
Technical View: SPDR S&P 500 ETF Trust breaks pivot high »

The SPDR S&P 500 ETF…

XLF

Financial Select Sector

$23.89

-0.09 (-0.38%)

XLV

Health Care Select Sector SPDR

$80.47

-0.12 (-0.15%)

SPY

SPDR S&P 500 ETF Trust

$243.13

0.29 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMGN

ImmunoGen

$6.06

0.24 (4.12%)

08:09
06/26/17
06/26
08:09
06/26/17
08:09
Hot Stocks
ImmunoGen presents data from Phase 1 study of IMGN779 in AML »

ImmunoGen presented data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

CBIO

Catalyst Biosciences

$4.53

0.02 (0.44%)

08:09
06/26/17
06/26
08:09
06/26/17
08:09
Hot Stocks
Catalyst says new data support ongoing trial of CB 2679d in hemophilia B »

Catalyst Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

NLSN

Nielsen

$37.46

0.32 (0.86%)

, FRED

Fred's

$10.25

0.38 (3.85%)

08:08
06/26/17
06/26
08:08
06/26/17
08:08
Hot Stocks
Nielsen, Fred's expand strategic analytics relationship »

Nielsen (NLSN) and…

NLSN

Nielsen

$37.46

0.32 (0.86%)

FRED

Fred's

$10.25

0.38 (3.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 27

    Jul

ATOS

Atossa Genetics

$0.53

0.0228 (4.50%)

08:07
06/26/17
06/26
08:07
06/26/17
08:07
Hot Stocks
Atossa says receives 'positive' interim safety assessment in Phase 1 study »

Atossa Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNF

FNF Group

$44.58

0.43 (0.97%)

08:07
06/26/17
06/26
08:07
06/26/17
08:07
Hot Stocks
FNF Group acquires majority stake in Title Guaranty of Hawaii »

Fidelity National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VC

Visteon

$95.91

1.05 (1.11%)

08:07
06/26/17
06/26
08:07
06/26/17
08:07
Upgrade
Visteon rating change  »

Visteon upgraded on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBHS

Fortune Brands

$66.05

0.96 (1.47%)

08:07
06/26/17
06/26
08:07
06/26/17
08:07
Hot Stocks
Fortune Brands Home & Security appoints Patrick Hallinan CFO »

Fortune Brands Home &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UN

Unilever; also tag UL

$55.68

0.08 (0.14%)

, UL

Unilever; also tag UN

$54.35

0.03 (0.06%)

08:06
06/26/17
06/26
08:06
06/26/17
08:06
Periodicals
Unilever threatens to pull ads from Google, Facebook, Times of London says »

Unilever (UN, UL) has…

UN

Unilever; also tag UL

$55.68

0.08 (0.14%)

UL

Unilever; also tag UN

$54.35

0.03 (0.06%)

GOOG

Alphabet

$965.59

8.5 (0.89%)

GOOGL

Alphabet Class A

$986.09

9.47 (0.97%)

FB

Facebook

$155.07

1.67 (1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

VSAT

ViaSat

$66.73

0.73 (1.11%)

08:06
06/26/17
06/26
08:06
06/26/17
08:06
Hot Stocks
ViaSat awarded $88.3M in contracts from SPAWAR »

ViaSat has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBRV

Nabriva Therapeutics

$10.55

0.05 (0.48%)

, TRVN

Trevena

$2.52

0.03 (1.20%)

08:06
06/26/17
06/26
08:06
06/26/17
08:06
Hot Stocks
Nabriva names CEO Colin Broom, Trevena CCO Carrie Bourow to board »

Nabriva Therapeutics…

NBRV

Nabriva Therapeutics

$10.55

0.05 (0.48%)

TRVN

Trevena

$2.52

0.03 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 06

    Jul

  • 26

    Sep

VOXX

VOXX

$7.85

0.25 (3.29%)

, TEL

TE Connectivity

$78.77

-0.04 (-0.05%)

08:05
06/26/17
06/26
08:05
06/26/17
08:05
Hot Stocks
VOXX to sell Hirschmann Car Communication to TE Connectivity »

VOXX International (VOXX)…

VOXX

VOXX

$7.85

0.25 (3.29%)

TEL

TE Connectivity

$78.77

-0.04 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOFT

Hooker Furniture

$39.40

-0.85 (-2.11%)

08:05
06/26/17
06/26
08:05
06/26/17
08:05
Conference/Events
Hooker Furniture management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

NEOT

Neothetics

$2.32

0.0501 (2.21%)

08:05
06/26/17
06/26
08:05
06/26/17
08:05
Hot Stocks
Neothetics: LIPO-202 did not demonstrate improvement in Phase 2 trial »

Neothetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTT

GTT Communications

08:05
06/26/17
06/26
08:05
06/26/17
08:05
Hot Stocks
GTT Communications to acquire Global Capacity »

GTT Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAFD

8point3 Energy

$14.62

0.22 (1.53%)

08:04
06/26/17
06/26
08:04
06/26/17
08:04
Hot Stocks
8point3 Energy increases quarterly distribution 3% to 26.42c per share »

8point3 Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

AMAG

AMAG Pharmaceuticals

$18.35

0.15 (0.82%)

, ATRS

Antares Pharma

$3.21

0.2 (6.64%)

08:04
06/26/17
06/26
08:04
06/26/17
08:04
Hot Stocks
AMAG Pharmaceuticals reports FDA filing acceptance for Makena sNDA »

AMAG Pharmaceuticals…

AMAG

AMAG Pharmaceuticals

$18.35

0.15 (0.82%)

ATRS

Antares Pharma

$3.21

0.2 (6.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 20

    Oct

VOXX

VOXX

$7.85

0.25 (3.29%)

, TEL

TE Connectivity

$78.77

-0.04 (-0.05%)

08:04
06/26/17
06/26
08:04
06/26/17
08:04
Hot Stocks
Breaking Hot Stocks news story on VOXX, TE Connectivity »

VOXX to sell Hirschmann…

VOXX

VOXX

$7.85

0.25 (3.29%)

TEL

TE Connectivity

$78.77

-0.04 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANY

Sphere 3D

$0.17

-0.0854 (-33.31%)

08:03
06/26/17
06/26
08:03
06/26/17
08:03
Conference/Events
Sphere 3D to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

FRTA

Forterra

$7.73

0.18 (2.38%)

08:03
06/26/17
06/26
08:03
06/26/17
08:03
Hot Stocks
Forterra to sell U.S. concrete, steel pressure pipe assets to Thompson Pipe »

Forterra announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

P

Pandora

$8.28

0.48 (6.15%)

, SIRI

SiriusXM

$5.35

0.11 (2.10%)

08:03
06/26/17
06/26
08:03
06/26/17
08:03
Recommendations
Pandora, SiriusXM analyst commentary  »

Pandora added to Alpha…

P

Pandora

$8.28

0.48 (6.15%)

SIRI

SiriusXM

$5.35

0.11 (2.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

TROV

Trovagene

$1.14

-0.16 (-12.31%)

08:02
06/26/17
06/26
08:02
06/26/17
08:02
Hot Stocks
Trovagene announces expansion of key claims for NPM1 patent portfolio »

Trovagene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBHC

National Bank

$31.55

-0.18 (-0.57%)

08:02
06/26/17
06/26
08:02
06/26/17
08:02
Conference/Events
National Bank to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 18

    Sep

CKPT

Checkpoint Therapeutics

$10.00

0.25 (2.56%)

, FBIO

Fortress Biotech

$4.87

0.05 (1.04%)

08:02
06/26/17
06/26
08:02
06/26/17
08:02
Hot Stocks
Checkpoint Therapeutics commences trading on Nasdaq Capital Market »

Checkpoint Therapeutics…

CKPT

Checkpoint Therapeutics

$10.00

0.25 (2.56%)

FBIO

Fortress Biotech

$4.87

0.05 (1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

SPA

Sparton

$18.34

0.03 (0.16%)

08:02
06/26/17
06/26
08:02
06/26/17
08:02
Hot Stocks
Sparton confirms discussions with Ultra Electronics »

Sparton Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.